Valuation Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.950 USD | +1.56% |
|
+15.38% | -19.75% |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 112 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -19.08% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 112 | 112 | 112 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -19.08% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -3.08x | -2.03x | -2.04x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | 3.92x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 11.2x | - | - |
| EV / Revenue | - | - | - | - | 0x | 11.2x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.34x | -2.06x | -1.75x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.59x | -1.59x | -1.2x |
| EV / FCF | 0x | 0x | -0x | -0x | 0x | -2.55x | -2.55x | 7x |
| FCF Yield | -53.3% | -130% | -46% | -51.5% | 21.4% | -39.3% | -39.3% | 14.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6322 | -0.9612 | -0.9562 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 10 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -47.8 | -54.3 | -63.9 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -43.34 | -70.25 | -93.14 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -34.14 | -66.03 | -89.49 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.950 | 1.950 | 1.950 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,454 | - | - |
| Announcement Date | 17/03/22 | 09/03/23 | 12/03/24 | 06/03/25 | 16/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.12x | - | - | - | 112M | |
| 20.56x | 7.11x | 14.62x | 1.42% | 68.12B | |
| 31.44x | 8.03x | 24.45x | 0.05% | 55.18B | |
| -82.4x | 15.59x | -64.97x | -.--% | 28.63B | |
| 30.46x | 5.97x | 15.8x | -.--% | 23.99B | |
| -14.71x | 5.23x | -6.82x | -.--% | 23.53B | |
| 25.47x | 4.76x | 15.94x | -.--% | 18.45B | |
| -1250.29x | 38.99x | -15519.34x | -.--% | 16.44B | |
| 47.61x | 19.33x | 49.78x | 0.08% | 15.83B | |
| 16.76x | 4.95x | 11.57x | -.--% | 13.4B | |
| Average | -117.82x | 12.22x | -1,717.66x | 0.17% | 26.37B | |
| Weighted average by Cap. | -68.05x | 10.40x | -960.50x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
